Ensysce Biosciences ENSC Balance Sheet (2017-2025)

NASDAQ ENSC
$0.47 +0.00 (+0.30%)
As of: Sep 9, 2026 · 3:59 PM EDT
Reported Financials

Ensysce Biosciences Quarterly Balance Sheet

Periods 33 quarters
Latest Dec 2025

Ensysce Biosciences reported total assets of $7.45M and total liabilities of $4.57M for the quarter ended Dec 2025, up 33.1% year over year. This balance sheet covers 33 quarters of results from Dec 2017 through Dec 2025, standardized by Business Quant from the company’s SEC filings.

Balance Sheet Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025
Assets
Current Assets
Cash & EquivalentsCash & Equiv.
0.25M8.01M6.85M12.26M8.44M3.73M4.50M3.15M1.42M3.83M1.46M1.12M3.40M1.04M4.15M3.50M3.05M2.21M1.67M4.31M
Cash & Current Investments
0.25M8.01M6.85M12.26M8.44M3.73M4.50M3.15M1.42M3.83M1.46M1.12M3.40M1.04M4.15M3.50M3.05M2.21M1.67M4.31M
Receivables - OtherOther Receivables
0.08M0.09M0.44M0.81M0.28M0.14M0.28M0.29M0.11M0.11M0.10M0.10M0.22M1.78M0.12M0.02M1.20M0.00M0.42M
Prepaid Assets
0.19M0.26M1.96M2.93M2.39M3.17M2.98M1.85M1.65M1.91M1.18M1.07M1.20M1.19M3.15M1.34M1.33M1.87M1.25M2.51M
Current Assets
0.23M8.36M8.92M15.66M11.66M7.19M7.66M5.30M3.37M5.86M2.76M2.29M4.70M2.46M9.09M5.34M4.40M5.28M2.93M7.25M
Non-Current Assets
Property, Plant & Equipment (Net)PP&E (Net)
50.000.12M0.12M
Long-Term Investments
12.69M
Long-Term Deferred Tax
Other Non-Current Assets
0.84M0.80M0.75M0.71M0.67M0.63M0.59M0.54M0.50M0.46M0.42M0.38M0.34M0.29M0.25M0.21M0.29M0.13M0.08M
Non-Current Assets
12.75M-7.29M-7.85M0.75M0.71M0.75M0.63M0.59M0.54M0.50M0.46M0.42M0.38M0.34M0.29M0.25M0.21M0.29M0.25M0.21M
Assets
12.98M1.07M1.07M16.42M12.37M7.95M8.29M5.89M3.91M6.36M3.22M2.71M5.07M2.80M9.38M5.60M4.61M5.57M3.18M7.45M
Liabilities
Current Liabilities
Accounts Payables
0.32M3.14M0.47M0.30M0.96M3.05M1.29M2.94M1.60M1.27M0.92M1.94M0.98M0.48M1.97M1.36M0.62M1.04M0.46M3.27M
Notes Payables
2.80M12.75M6.07M2.52M7.55M4.27M0.45M0.35M0.85M0.25M0.45M0.39M0.30M0.26M0.42M0.39M0.31M
Payables
0.32M3.14M3.27M13.05M7.03M5.57M8.84M7.21M1.60M1.72M1.27M2.79M1.23M0.94M2.35M1.66M0.87M1.47M0.85M3.57M
Accumulated Expenses
0.41M
Other Accumulated Expenses
0.41M3.73M3.41M1.75M2.67M2.24M2.23M2.36M0.79M0.76M0.54M0.41M0.37M0.45M0.55M0.89M1.05M1.45M0.99M
Current Leases
0.01M0.03M0.02M0.02M0.01M0.04M0.03M0.02M0.01M0.00M
Current Taxes
Total Current Liabilities
0.32M4.03M7.03M16.48M8.80M8.25M11.91M9.46M3.98M2.52M2.03M3.33M1.64M1.31M2.80M2.21M1.76M2.51M2.30M4.57M
Non-Current Liabilities
Non-Current Debt
0.47M4.91M17.19M7.66M2.66M8.94M4.41M0.45M0.35M0.85M0.25M0.45M0.39M0.30M0.26M0.42M0.39M0.31M
Convertible Debt
5.00M5.00M
Non-Current Deffered Revenue
2.00M
Preferred Stock Liabilities
Minority Interest
-0.24M-0.28M-0.28M-0.28M-0.31M-0.33M-0.32M-0.32M-0.33M-0.33M-0.33M-0.33M-0.33M-0.33M-0.33M-0.33M-0.33M-0.33M-0.33M
Non-Current Deferred Tax LiabilityNon-Current Deferred Tax
Other Non-Current Liabilities
8.31M0.96M3.65M0.87M0.36M1.41M0.31M0.09M0.05M0.03M0.03M0.02M0.01M0.00M0.01M0.13M0.00M35.00
Total Non-Current Liabilities
2.78M3.07M8.09M2.46M8.39M2.80M0.45M0.09M0.05M0.03M0.03M0.02M0.01M0.00M0.01M0.13M0.00M35.00
Total Liabilities
11.09M4.03M10.10M24.58M11.26M8.75M14.71M9.91M4.07M2.56M2.06M3.36M1.65M1.32M2.80M2.22M1.89M2.51M2.30M4.57M
Shareholder's Equity
Total Debt
0.47M7.71M29.94M13.73M5.18M16.49M8.67M0.89M0.70M1.71M0.49M0.91M0.77M0.60M0.51M0.85M0.78M0.61M
Common Equity
-7.30M150.00M-0.39M-8.16M1.11M-0.80M250.00M-4.03M-0.15M3.79M1.16M-0.65M3.42M1.48M6.58M3.38M2.72M3.06M1.20M3.21M
Liabilities and Shareholders Equity
12.98M1.07M1.07M16.42M12.37M7.95M8.29M5.89M3.91M6.36M3.22M2.71M5.07M2.80M9.38M5.60M4.61M5.57M3.18M7.45M
Retained Earnings
4.81M63.25M-75.01M-85.85M88.90M-95.51M-105.41M-110.93M113.29M119.48M119.54M-121.56M128.42M128.45M132.89M133.25M134.54M136.61M138.16M142.93M
Preferred Shares
1.50M1.50M3.64M